QTRX (Quanterix) Valuation Rank


QTRX Quanterix Corp QTRX
58 GF Score
Price $4.28
GF Value $11.68
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Quanterix Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Quanterix Valuation Rank Related Terms

QTRX
58GF Score
Quanterix Corp QTRX
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Quanterix (QTRX) Overvalued in 2026?

Based on GuruFocus' analysis, Quanterix stock appears to be undervalued. The current stock price of $4.28 is trading 63.4% below its estimated GF Value™ of $11.68. GuruFocus considers Quanterix to be Possible Value Trap.

Key valuation signals for QTRX:

  • Valuation Rank:
  • GF Value™: $11.68 vs. price of $4.28 (63.4% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the QTRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Quanterix Business Description

Address 900 Middlesex Turnpike, Billerica, MA, USA, 01821
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
58GF Score

Get the complete analysis for QTRX

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.28
Price
$11.68
GF Value